We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Infection and death rates are the world’s highest and vaccination take-up is low, forcing renewed restrictions
Concern over booster campaign as advisers urge government to prepare for ‘rapid deployment’ of tighter Covid restrictions
US regulatory shake-up will mainly effect people who would otherwise have gone without
Asia-Pacific countries ease restrictions on passengers vaccinated against Covid-19
Ministers weigh fresh restrictions as medics juggle flu cases with rise in emergency demand and patient backlog
Results hailed as ‘important’ but duration of protection still unknown
British Medical Association claims UK government is being ‘wilfully negligent’ in refusing to act
Narendra Modi celebrates ‘triumph of Indian science’ months after devastating second wave
Health secretary urges people to get booster jabs to avoid fresh restrictions
Russian workplaces to shut down from October 30 amid rising case numbers and deaths
Demand comes as daily death toll hits highest level since March and hospitalisations near 1,000
Suggestion ex-secretary of state would have benefited from treatment dismissed as ‘highly speculative’
New half-term vaccine push for teens comes as ministers question progress of third-jab programme
Scientist say AY.4.2 seems to be 10%-15% more transmissible but cannot be blamed for high UK Covid-19 case numbers
Head of Royal College of Pathologists says NHS backlog cannot be cleared without more investment in his field
Deaths and hospital admissions remain stubbornly high in Britain as the continent reports record lows
Seasonal shortages are a spur to manufacturers to invest in capacity
Panel recommends third jabs for vulnerable people in step towards expanding US rollout of extra doses
Deaths from TB increase for first time in over a decade despite confirmed cases falling
Personalised cancer treatments are among those being developed using a technology once distrusted by big pharma
Japanese pharma company says Medicago’s product will be cheaper to make and easier to transport
IMF warns uneven pace of immunisation raises risks of economic scarring
German biotech had suffered disappointing results after initial excitement
Molnupiravir has limitations but drugmakers should be able to build on it to create other treatments
Drugmaker seeks authorisation from FDA for oral treatment shown to prevent severe disease in vulnerable people
International Edition
